Docquier Léa, Beklevic Ishak, Treille de Grandseigne Serge, Guillaume Benoit, Pourcelet Aline
Université Libre de Bruxelles, Bruxelles, Belgium.
CHU Marie-Curie Humani, Charleroi, Belgium.
Eur J Case Rep Intern Med. 2024 Nov 19;11(12):004847. doi: 10.12890/2024_004847. eCollection 2024.
We report on a 67-year-old male patient admitted to the Internal Medicine department for fever, joint pain and exertional dyspnoea. Two months before his admission, the patient had been diagnosed with pauci-immune necrotising glomerulonephritis, for which he had been treated with rituximab and corticosteroids. Upon admission the patient was stable, but within a few hours he became unstable as liver failure and acute cytopaenia occurred. Blood investigations revealed cytopaenia, altered coagulation tests, high ferritin, triglycerides, lactate dehydrogenase and C-reactive protein levels, and severe cytocholestasis. A liver echography was normal. The patient had been transferred to the intensive care unit to receive supportive support when the cytomegalovirus polymerase chain reaction (CMV-PCR) test came back positive. The diagnosis of haemophagocytic lymphohistiocytosis associated with a CMV infection and/or reactivation in an immunosuppressed patient was made. Specific treatment was administrated, along with symptomatic treatment. The patient clinically improved during hospitalisation with complete resolution of symptoms.
Haemophagocytic lymphohistiocytosis (HLH) is a rare disease yet important to diagnose, as it is quickly life-threatening.The diverse symptoms of HLH can make diagnosis tricky, with many potential causes. As clinical presentation is not very specific, it is often mistaken for infection with severe sepsis and its diagnosis is often delayed.Limited understanding of this condition could lead to worse outcomes for patients. Recognising it early is crucial for starting the right treatment and enhancing both the well-being and survival chances of those affected by this complex disorder.In practice, HLH must be suspected when bi/pancytopaenia occurs in a patient presenting a high fever of unknown cause, especially when they have a history of immunosuppression. Managing it often requires a range of approaches, such as intensive care, immune system suppression, specialised medications or even stem cell transplants.
我们报告了一名67岁男性患者,因发热、关节疼痛和劳力性呼吸困难入住内科。入院前两个月,该患者被诊断为寡免疫性坏死性肾小球肾炎,接受了利妥昔单抗和皮质类固醇治疗。入院时患者情况稳定,但数小时内病情恶化,出现肝衰竭和急性血细胞减少。血液检查显示血细胞减少、凝血试验异常、铁蛋白、甘油三酯、乳酸脱氢酶和C反应蛋白水平升高,以及严重的胆汁淤积。肝脏超声检查正常。当巨细胞病毒聚合酶链反应(CMV-PCR)检测结果呈阳性时,患者已被转入重症监护病房接受支持治疗。诊断为免疫抑制患者中与CMV感染和/或再激活相关的噬血细胞性淋巴组织细胞增生症。给予了特异性治疗及对症治疗。患者住院期间临床症状改善,症状完全缓解。
噬血细胞性淋巴组织细胞增生症(HLH)是一种罕见但重要的疾病,因其可迅速危及生命。HLH的多样症状可能使诊断变得棘手,有许多潜在病因。由于临床表现不太特异,它常被误诊为严重脓毒症感染,诊断往往延迟。对这种疾病的了解有限可能导致患者预后更差。早期识别对于开始正确治疗以及提高受这种复杂疾病影响者的健康水平和生存机会至关重要。在实践中,当不明原因高热患者出现双/全血细胞减少时,尤其是有免疫抑制病史时,必须怀疑HLH。其治疗通常需要一系列方法,如重症监护、免疫系统抑制、特殊药物治疗甚至干细胞移植。